Mandai Koichiro, Tsuchiya Takayoshi, Kawakami Hiroshi, Ryozawa Shomei, Saitou Michihiro, Iwai Tomohisa, Ogawa Takahisa, Tamura Takashi, Doi Shinpei, Okabe Yoshinobu, Chiba Yasutaka, Itoi Takao
Department of Gastroenterology, Kyoto Second Red Cross Hospital, Kyoto City, Japan.
Department of Gastroenterology and Hepatology, Tokyo Medical University, Shinjuku-ku City, Japan.
J Hepatobiliary Pancreat Sci. 2022 Nov;29(11):1185-1194. doi: 10.1002/jhbp.1090. Epub 2021 Dec 11.
BACKGROUND/PURPOSE: Whether a fully covered self-expanding metal stent (FCSEMS) or plastic stent (PS) is preferable for preoperative biliary drainage in patients with resectable pancreatic cancer (RPC) is controversial. This study aimed to evaluate the safety and efficacy of drainage with FCSEMS for obstructive jaundice caused by RPC without neoadjuvant chemotherapy.
Seventy patients with RPC who required preoperative biliary drainage were randomly assigned 1:1 to the FCSEMS or PS group. The primary endpoint was endoscopic re-intervention rate during the waiting period for surgery. Secondary endpoints were drainage procedure time, drainage-related adverse events (AE), waiting period for surgery, operative time, intraoperative blood loss, surgery-related AE, and postoperative hospital stay.
Thirty-nine patients underwent surgery. None required re-intervention in the FCSEMS group, whereas five PS patients underwent re-intervention (P = .023). The FCSEMS group had significantly more intraoperative blood loss (P = .0068) and AE (P = .011) than the PS group. Postoperative hospital stay was significantly longer in the FCSEMS group (P = .016).
Fully covered self-expanding metal stent had a lower rate of endoscopic re-intervention during the waiting period for surgery than PS, but showed more intraoperative blood loss, higher incidence of surgery-related AE, and longer postoperative hospital stays.
背景/目的:对于可切除胰腺癌(RPC)患者,术前胆道引流采用全覆膜自膨式金属支架(FCSEMS)还是塑料支架(PS)更好,目前存在争议。本研究旨在评估FCSEMS用于未接受新辅助化疗的RPC所致梗阻性黄疸引流的安全性和有效性。
70例需要术前胆道引流的RPC患者按1:1随机分为FCSEMS组或PS组。主要终点是手术等待期的内镜再次干预率。次要终点包括引流操作时间、引流相关不良事件(AE)、手术等待期、手术时间、术中失血、手术相关AE及术后住院时间。
39例患者接受了手术。FCSEMS组无一例需要再次干预,而PS组有5例患者接受了再次干预(P = 0.023)。FCSEMS组术中失血(P = 0.0068)和AE(P = 0.011)明显多于PS组。FCSEMS组术后住院时间明显更长(P = 0.016)。
全覆膜自膨式金属支架在手术等待期的内镜再次干预率低于PS,但术中失血更多,手术相关AE发生率更高,术后住院时间更长。